Our study has made groundbreaking progress in identifying key transcription factors, such as SP1, E2F1, and SIN3A, as well as kinases, including MAPK14, CSNK2A1, and CDC2, whose role in breast cancer progression is paramount (Figure 5). This evidence concerns the gene E2F1 and breast carcinoma.